Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

102.65 -0.44 (-0.43%)

Streaming Delayed Price Updated: 2:40 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about BioNTech SE - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

60 61 Next >

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment ↗

June 18, 2024

AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a...

Via Benzinga

Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? ↗

June 17, 2024

BioNTech partner MediLink Therapeutics faces a partial clinical hold from the FDA on the Phase 1 trial of BNT326/YL202 for advanced non-small cell lung cancer and HR+/HER2-negative breast cancer.

Via Benzinga

Evaluating BioNTech: Insights From 15 Financial Analysts ↗

June 10, 2024

Via Benzinga

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season ↗

June 07, 2024

Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.

Via Benzinga

What's Going On With Novavax Stock? ↗

June 05, 2024

Novavax, Inc. shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look at what's going on.

Via Benzinga

Critical Insights From BioNTech Analyst Ratings: What You Need To Know ↗

May 24, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For BioNTech ↗

May 07, 2024

Via Benzinga

Assessing BioNTech: Insights From 11 Financial Analysts ↗

April 17, 2024

Via Benzinga

Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership ↗

June 01, 2024

Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in...

Via Talk Markets

Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, ↗

May 28, 2024

Jim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported better-than-expected first-quarter financial results.

Via Benzinga

Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In Your Portfolio? ↗

May 26, 2024

Top-performing stocks last week were FSLR, MRNA, ELF, NVDA, IP, ADI, FLEX, LOGI, BNTX, and MNDY, boosted by positive news and analyst targets.

Via Benzinga

Why Vaccine Stocks Rallied This Week ↗

May 24, 2024

A bird flu outbreak could spur demand for vaccines from these key players, but is it likely?

Via The Motley Fool

Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb ↗

May 22, 2024

Experts predict a small rise in COVID-19 cases as a newly dominant strain spreads. The new strain, KP.2, represents 28% of Covid infections in the U.S. and experts believe its mutations have made the...

Via Benzinga

Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday ↗

May 22, 2024

Via Benzinga

3 Blue-Chip Stocks Set to Triple Soon ↗

May 20, 2024

Blue-chip stocks are great additions to a portfolio. If you're looking for consistent returns, check out these blue-chip stocks to buy.

Via InvestorPlace

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech ↗

May 17, 2024

Moderna wins a crucial legal battle at the European Patent Office against Pfizer and BioNTech over Covid-19 vaccine patents.

Via Benzinga

Topics Intellectual Property

Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential' ↗

May 09, 2024

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

Via Benzinga

BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript ↗

May 06, 2024

BNTX earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

BNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q1 2024 ↗

May 06, 2024

BNTX stock results show that BioNTech missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

What's Going With BioNTech Stock On Monday? ↗

May 06, 2024

BioNTech reports Q1 loss, missing revenue expectations. Despite challenges, BioNTech aims for significant growth, fueled by innovative R&D and strong cash reserves.

Via Benzinga

BioNTech Slides After Reporting Losses As Covid Vaccine Sales Take A Hit ↗

May 06, 2024

BioNTech missed the Street's sales views and reported wider-than-expected losses.

Via Investor's Business Daily

BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

May 06, 2024

Via Benzinga

Wall Street Looks To Extend Rally Amid Caution Over Fed Speeches, More Earnings: Why This Analyst Thinks Bull Market Is Still 'Quite Young' ↗

May 06, 2024

U.S. stocks are likely to extend their gains as major index futures are modestly higher on Monday. Strong earnings reports continue to support the market, with S&P 500 earnings expected to grow by 5%...

Via Benzinga

Topics Economy

GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook ↗

May 01, 2024

Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Specialty Medicines, propelled by strong demand for Arexvy and Shingrix....

Via Benzinga

Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report ↗

May 06, 2024

According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far.

Via Benzinga

Topics Stocks

COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle ↗

April 26, 2024

Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent...

Via Benzinga

Topics Intellectual Property Lawsuit

What's Going On With Pfizer Stock On Thursday? ↗

April 25, 2024

GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying high-stakes legal battles in the U.S.

Via Benzinga

Topics Intellectual Property

Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown ↗

April 23, 2024

Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams.

Via Benzinga

Topics Intellectual Property

Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert ↗

April 12, 2024

Via Benzinga

Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024? ↗

April 09, 2024

These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

60 61 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.